GEN Exclusives

More »

GEN News Highlights

More »
Dec 4, 2007

Oracle to Acquire Precision Therapeutics

  • Oracle Healthcare Acquisition plans to take over Precision Therapeutics (PTI) in a stock-for-stock agreement. PTI will merge with a Oracle subsidiary, which will then be renamed Precision Therapeutics.

    PTI develops and commercializes tests to assist physicians in individualizing cancer therapy. The company markets ChemoFx®, a cell-based test that examines the likelihood of patients’ tumor response to various chemotherapies. The company has ongoing clinical trials involving tests related to breast and ovarian cancers.

    “We are very excited about this merger as it would provide the financial resources to capitalize on the progress we have made in commercializing our ChemoFx test,” states Sean McDonald, president and CEO of PTI. “The capital available to us upon the closing of the transaction would support an increased sales and marketing effort, which should allow us to continue the rapid revenue growth that we have been experiencing.”

    Oracle expects to have its shares trade on NASDAQ. The company anticipates having approximately $120 million in cash at the closing, before payment of expenses of the merger and cash paid to any PTI and Oracle stockholders.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »